MAPK1 and cancer: As a result, V600E–mutant BRAF that dimerizes with other RAF mutants or with wild-type BRAF or CRAF exhibit drug resistance due to the unintended paradoxical activation of ERK,322,389,393 which may also be responsible for the elevated toxicity and disruption in RAF signaling observed in non-cancer cells.